Adrenal gland cancer metastatic and Ideational apraxia

Summary:

Ideational apraxia is reported only by a few people with Adrenal gland cancer metastatic.

The study analyzes which people have Ideational apraxia with Adrenal gland cancer metastatic. It is created by eHealthMe based on 1 person who has Ideational apraxia and Adrenal gland cancer metastatic from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 28, 2023

1 person who has Adrenal Gland Cancer Metastatic and Ideational Apraxia is studied.


What is Adrenal gland cancer metastatic?

Adrenal gland cancer metastatic (adrenal gland cancer-spread of cancer to other parts of the body) is found to be associated with 100 drugs and 34 conditions by eHealthMe.

What is Ideational apraxia?

Ideational apraxia (neurological disorder -difficulty with actions requiring planning) is found to be associated with 1,014 drugs and 839 conditions by eHealthMe.

Number of Ideational apraxia in Adrenal gland cancer metastatic reports submitted per year:

Would you have Ideational apraxia when you have Adrenal gland cancer metastatic?

Gender of people who have Adrenal Gland Cancer Metastatic and experienced Ideational Apraxia *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Adrenal Gland Cancer Metastatic and experienced Ideational Apraxia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Adrenocortical Carcinoma (adrenal cortex cancer): 1 person, 100.00%

Common drugs taken by these people *:

  1. Etoposide: 1 person, 100.00%
  2. Eprex: 1 person, 100.00%
  3. Carboplatin: 1 person, 100.00%

Common symptoms for these people *:

  1. Weakness: 1 person, 100.00%
  2. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 1 person, 100.00%
  3. Motormental Retardation (a slowing-down of thought and a reduction of physical work): 1 person, 100.00%
  4. Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 1 person, 100.00%
  5. Memory Loss: 1 person, 100.00%
  6. Hallucinations (sensations that appear real but are created by your mind): 1 person, 100.00%
  7. Confusional State: 1 person, 100.00%
  8. Confusion: 1 person, 100.00%
  9. Acalculia (loss of the ability to perform calculations): 1 person, 100.00%
  10. Abnormal Behavior: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ideational apraxia?

Check whether Ideational apraxia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Ideational apraxia:

All the drugs that are associated with Ideational apraxia:

Common conditions associated with Ideational apraxia:

All the conditions that are associated with Ideational apraxia:

How the study uses the data?

The study is based on Ideational apraxia and Adrenal gland cancer metastatic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: